• PDB2 THE IMPACT OF ORAL ANTIDIABETICS ON WEIGHT IN THE ELDERLY WITH TYPE 2 DIABETES MELLITUS IN THE AMBULATORY SETTING

    May 1, 2010, 00:00

  • PDB29 COST/EFFECTIVENESS STUDY OF THIAZOLIDINEDIONES IN DIABETIC MEDICATION-A TAIWANESE EMPIRICAL STUDY

    May 1, 2010, 00:00

  • PMH77 THE RELIABILITY AND VALIDITY OF THE CLEAR THINKING SCALE (CTS) AMONG PATIENTS DIAGNOSED WITH SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PCN124 IDEAL VIAL SIZE FOR BORTEZOMIB- REAL WORLD DATA ON WASTE AND COST REDUCTION IN MULTIPLE MYELOMA (MM)

    May 1, 2010, 00:00

  • PCV52 COMPLIANCE AND HEALTH CARE UTILIZATION AMONG PATIENTS WITH HYPERTENSION TREATED WITH SINGLE PILL VS. FREE COMBINATION ANTIHYPERTENSIVE THERAPY- U.S. NATIONAL AND STATE LEVEL RESULTS FROM A CLAIMS DATABASE ANALYSIS

    May 1, 2010, 00:00

  • PCV144 DERIVING DOCTORS PRESCRIBING PATTERNS FROM CLAIMS DATA- AN APPLICATION TO ANTICOAGULANT USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

    May 1, 2010, 00:00

  • PND19 IMPACT OF MEDICATION ADHERENCE TO DISEASE-MODIFYING DRUGS ON SEVERE RELAPSE, AND DIRECT AND INDIRECT COSTS AMONG EMPLOYEES WITH MULTIPLE SCLEROSIS

    May 1, 2010, 00:00

  • PCN104 ESTIMATION AND COMPARISON OF EQ-5D HEALTH STATES UTILITY WEIGHTS FOR PNEUMOCCOCAL AND HUMAN PAPILLOMAVIRUS DISEASES IN ARGENTINA, CHILE AND THE UNITED KINGDOM

    May 1, 2010, 00:00

  • PCN48 NON-ADHERENCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IS ASSOCIATED WITH SHORT- AND LONG-TERM NEGATIVE IMPACTS ON HEALTH CARE RESOURCE UTILIZATION AND COSTS

    May 1, 2010, 00:00

  • PDB78 RANDOMIZED CLINICAL TRIAL (RCT) DESIGN AND ANALYTIC ISSUES IMPACTING ASSUMED CLINICAL EFFECTS AND RESULTS OF COST-EFFECTIVENESS ANALYSES- ILLUSTRATION FROM A RECENT CANADIAN REPORT ON THE COST-EFFECTIVENESS OF BLOOD GLUCOSE TEST STRIP ...

    May 1, 2010, 00:00

  • PCN47 COMPARISON OF HEALTH CARE RESOURCE UTILIZATION AND COSTS BETWEEN NILOTINIB AND DASATINIB AS SECOND LINE THERAPIES IN CHRONIC MYELOID LEUKEMIA (CML)

    May 1, 2010, 00:00

  • PND24 EVALUATING THE IMPACT OF RESTLESS LEGS SYNDROME (RLS) ON NEXT DAY FUNCTIONING

    May 1, 2010, 00:00

  • PRS7 TRIPLE THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    May 1, 2010, 00:00

  • PDB48 ASSESSING QUALITY OF LIFE IN SHORT STATURE YOUTH - THE QOLISSY PROJECT FOCUS GROUP AND COGNITIVE DEBRIEFING EXPERIENCE

    May 1, 2010, 00:00

  • PGI36 USING PROPENSITY SCORE MATCHING TO ESTIMATE DIFFERENCES IN HEALTH CARE UTILIZATION BETWEEN PEOPLE WITH AND WITHOUT ULCERATIVE COLITIS

    May 1, 2010, 00:00

  • PMH67 REFUSAL OF ANCILLARY SUPPORT SERVICES EARLY IN TREATMENT PREDICTS SIX MONTH OUTCOMES AMONG BUPRENORPHINE-MEDICATION ASSISTED TREATMENT PATIENTS

    May 1, 2010, 00:00

  • PDB74 TREATMENT OF TYPE 2 DIABETES VS. CLINICAL GUIDELINES

    May 1, 2010, 00:00

  • PMC24 THE EFFECT OF FRAMING ON PREFERENCES FOR MAXIMIZING QALYS

    May 1, 2010, 00:00

  • PIN29 COST-EFFECTIVENESS OF THE SEQUENTIAL USE OF ANIDULAFUNGIN AND ORAL VORICONAZOLE IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NON-NEUTROPHENIC PATIENTS IN MEXICO

    May 1, 2010, 00:00

  • PND20 PERCEIVED CAREGIVER BURDEN AND HEALTH RELATED QUALITY OF LIFE IN ALZHEIMERS CAREGIVERS

    May 1, 2010, 00:00

  • PCN67 COST-UTILITY OF KRAS MUTATION TESTING PRIOR TO TREATMENT OF METASTATIC COLORECTAL CANCER WITH CETUXIMAB MONOTHERAPY

    May 1, 2010, 00:00

  • PIN13 IMPACT ON COST OF INAPPROPRIATE INITIAL EMPIRICAL USE OF ANTIBIOTIC IN PATIENTS WITH COMPLICATED INFECTIONS FROM TWO LARGE BRAZILIAN HOSPITALS

    May 1, 2010, 00:00

  • PMC25 PATIENT PREFERENCES FOR ADHERENCE TOOLS ACROSS 10 MEDICAL CONDITIONS

    May 1, 2010, 00:00

  • PDB18 COSTS OF DIABETES TREATMENT IN THE MEXICAN PRIVATE SECTOR

    May 1, 2010, 00:00

  • PCV130 EVALUATION ON THE DRUGS AND MEDICAL COST OF PATIENTS WITH HYPERTENSION IN CHINA

    May 1, 2010, 00:00

  • PND18 HEALTH STATUS, RESOURCE UTILIZATION, AND WORK PRODUCTIVITY FOR CAREGIVERS OF ADULTS WITH EPILEPSY- A PROPENSITY SCORE ANALYSIS OF NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PMH86 AGE RELATED TREATMENT DIFFERENCES AMONG CHILDREN WITH BIPOLAR SPECTRUM DISORDERS

    May 1, 2010, 00:00

  • PDB35 COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VS. METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE 2 DIABETES PATIENTS IN ARGENTINA

    May 1, 2010, 00:00

  • PHP13 MEDICARE PART D AND ITS IMPACT ON PRESCRIPTION DRUG USE

    May 1, 2010, 00:00

  • PHP64 MORTALITY RATE COMPARISON BETWEEN STATES WITH AND WITHOUT PRESCRIPTION DRUG MONITORING PROGRAMS AND ASSOCIATED FEDERAL COSTS

    May 1, 2010, 00:00

  • PCV158 RARE EVENT BIAS IN RETROSPECTIVE ANALYSIS OF OUTCOMES MEASURES

    May 1, 2010, 00:00

  • PCV33 WHAT IS THE IMPACT OF SWITCHING FROM AN ACE INHIBITOR TO AN ANGIOTENSIN RECEPTOR BLOCKER ON BLOOD PRESSURE AND CARDIOVASCULAR EVENTS?

    May 1, 2010, 00:00

  • PCN72 ECONOMIC EVALUATION OF SUNITINIB VS. INTERFERON-A AND BEVACIZUMAB INTERFERON-A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (CCRM) - BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE

    May 1, 2010, 00:00

  • PRS26 COST-UTILITY ANALYSIS OF TIOTROPIUM, MEDICINE FOR CHRONIC OBSTRACTIVE PULMONARY DISEASES (COPD), IN JAPAN

    May 1, 2010, 00:00

  • PCN129 RACIAL DISPARITIES ASSOCIATED WITH TREATMENT AND SURVIVAL IN ELDERLY PATIENTS WITH EARLY STAGE OPERABLE BREAST CANCER

    May 1, 2010, 00:00

  • PCV74 COST-EFFECTIVENESS OF STATIN THERAPY FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS PREDICTED BY THE REYNOLDS RISK SCORE IN HEALTHY MEN AND WOMEN AGED 40 TO 80 YEARS OF AGE

    May 1, 2010, 00:00

  • PMH91 EXAMINATION OF DOCTORS PRACTICE AND PRESCRIBING PATTERNS TOWARD SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND SERTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS

    May 1, 2010, 00:00

  • PHP22 UTILIZATION OF PRESCRIBED PAIN MEDICATIONS PRIOR TO THE INITIATION OF DULOXETINE THERAPY

    May 1, 2010, 00:00

  • PCN97 ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CETUXIMAB TREATMENT DECISION MODEL- CHEMOTHERAPYCETUXIMAB VS. CETUXIMAB TREAT-TO-RASH STRATEGY VS. CHEMOTHERAPY ONLY IN FIRST-LINE TREATMENT OF STAGE IIIB/IV NSCLC

    May 1, 2010, 00:00

  • PCV50 COST OF VTE EVENTS FOR MEDICARE PATIENTS UNDERGOING MAJOR ORTHOPAEDIC SURGERIES ACCORDING TO DISCHARGE STATUS

    May 1, 2010, 00:00

  • PHP95 ANALYSIS OF 'BRIDGING THERAPY' IN ORTHOPEDIC PATIENTS IN A U.S. HEALTH PLAN

    May 1, 2010, 00:00

  • PUK4 EFFECT OF ATYPICAL ANTIPSYCHOTICS ON URINARY INCONTINENCE IN US NURSING HOME RESIDENTS USING PSYCHOTROPIC MEDICATIONS

    May 1, 2010, 00:00

  • PCN99 ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKAEMIA IN PATIENTS RESISTANT TO IMATINIB IN COLOMBIA AND VENEZUELA

    May 1, 2010, 00:00

  • PMS73 OPERATIVE RISK OF STAGED BILATERAL KNEE REPLACEMENT IS UNDER-ESTIMATED IN RETROSPECTIVE STUDIES

    May 1, 2010, 00:00

  • PMH75 EFFECT OF EQUIVALENT AND NON-EQUIVALENT SUBSTITUTION OF PRESCRIBED DRUGS FOR DEPRESSION AND ANXIETY DISORDERS ON PATIENTS TREATMENT ADHERENCE AND PERCEPTION

    May 1, 2010, 00:00

  • PIN37 COST EFFECTIVENESS ANALYSES (CEA) OF LOPINAVIR/RITONAVIR (LPV/R) AND ATAZANAVIR PLUS RITONAVIR (ATV VE HIV-I INFECTED PATIENTS BASED ON CASTLE 48-WEEK STUDY- APPLICATION TO GERMANY, ITALY, SPAIN, AND THE UNITED KINGDOM

    May 1, 2010, 00:00

  • PGI18 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPE I CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PM1 RISK-BENEFIT FRAMEWORK FOR EVALUATION OF GENE EXPRESSION PROFILING IN WOMEN WITH EARLY STAGE BREAST CANCER- A DECISION MODEL DEVELOPED IN COLLABORATION WITH STAKEHOLDERS

    May 1, 2010, 00:00

  • PCV34 ATRIALL FIBRILLATION EPIDEMIOLOGY AND MANAGEMENT IN PRIMARY CARE

    May 1, 2010, 00:00

  • PSY45 IMPACT OF ACUTE BLEEDING AND ADMINISTRATION OF BYPASSING AGENTS (BPA) ON DAILY ACTIVITIES OF PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR CAREGIVERS AND FAMILIES- OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUD ...

    May 1, 2010, 00:00

  • PMC41 PATIENT-REPORTED OUTCOMES IN CLINICAL RESEARCH- PRESENT STATUS AND A LOOK TO THE FUTURE

    May 1, 2010, 00:00

  • PHP72 ASSESSING THE IMPACT AND VALUE OF HEALTH OUTCOMES PUBLICATIONS USING CITATION DATA FROM INDICES OF SCHOLARLY LITERATURE

    May 1, 2010, 00:00

  • PSY26 COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN BRAZIL

    May 1, 2010, 00:00

  • PCV126 THE CARDIOVASCULAR CONSEQUENCES OF SWITCHING FROM ATORVASTATIN TO GENERIC SIMVASTATIN IN THE NETHERLANDS

    May 1, 2010, 00:00

  • PR1 INCORPORATING TARIFF-LEVEL UNCERTAINTY AROUND ESTIMATES FROM THE CATALOGUE OF EQ-5D SCORES

    May 1, 2010, 00:00

  • PRS46 TEN YEAR TRENDS IN PRESCRIPTION OF CHRONIC OBSTRUCTIVE PULMONARY MEDICATION AMONG ADULTS FROM 1996 TO 2005

    May 1, 2010, 00:00

  • PSY13 COMPARISON OF TOTAL HEALTH CARE EXPENDITURES AND ABSENTEEISM FOR INFLAMMATORY BOWEL DISEASE FROM AN EMPLOYERS PERSPECTIVE

    May 1, 2010, 00:00

  • UT2 COMPARISON OF HEALTH STATE UTILITY ESTIMATES IN COST-EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • PDB6 RELATIVE EFFECTIVENESS MANAGEMENT OF TYPE II DIABETES IN EUROPE- CAN THE AGENCIES DEMANDS BE MET?

    May 1, 2010, 00:00

  • PCV96 IMPACT OF MEDICARE PART D ON ADHERENCE AND PERSISTENCE WITH STATIN MEDICATIONS FOR TEXAS DUAL-ELIGIBLE BENEFICIARIES

    May 1, 2010, 00:00

  • PHP49 POTENTIAL SAVINGS FROM BROAD USE OF 4 GENERIC DRUGS- 2007 MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2010, 00:00

  • PCV125 UTILIZATION PATTERNS FOR ANTIARRHYTHMIC DRUGS IN BIG 5 EU MARKETS- TEMPORAL ANALYSIS FROM 2005 TO 2009

    May 1, 2010, 00:00

  • CN1 MODELING THE IMPACT OF TECHNOLOGY DIFFUSION IN BREAST CANCER TREATMENT ON THE COST-EFFECTIVENESS OF MAMMOGRAPHY SCREENING

    May 1, 2010, 00:00

  • Abstracts Index

    May 1, 2010, 00:00

  • PHP32 ASSOCIATION OF PAYER STATUS WITH LENGTH OF STAY IN PATIENTS HOSPITALIZED FOR INJURY IN 2006 NHAMCS-ED DATA

    May 1, 2010, 00:00

  • PCN2 DIABETIC MEDICATIONS AND ITS ASSOCIATION WITH MORTALITY IN HOSPITALIZED CANCER PATIENTS

    May 1, 2010, 00:00

  • PCV70 COST-EFFECTIVENESS OF ROSUVASTATIN 20 MG IN SECONDARYPREVENTION PATIENTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PUK5 DOES RACIAL VARIATION IN RISK FACTORS HAVE A ROLE TO PLAY IN THE INCIDENCE OF CHRONIC KIDNEY DISEASE IN THE US POPULATION

    May 1, 2010, 00:00

  • PCV4 COMPARISON OF MORTALITY, RE-HOSPITALIZATION AND BLEEDING RATES OF MEDICARE PATIENTS WHO UNDERWENT KNEE REPLACEMENT SURGERY AND SUFFERED VENOUS THROMBOEMBOLISM VERSUS NO VENOUS THROMBOEMBOLISM

    May 1, 2010, 00:00

  • PIH25 PSYCHOMETRIC PROPERTIES OF THE OXFORD WORRIES ABOUT LABOUR SCALE (OWLS)

    May 1, 2010, 00:00

  • PIN14 REDUCTION OF ACUTE OTITIS MEDIA IN CHILDREN- A COST-CONSEQUENCE ANALYSIS OF A 7-, 10-AND 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CANADA

    May 1, 2010, 00:00

  • PMS24 COST-EFFECTIVENESS COMPARATIVE ANALYSIS OF BISPHOSPHONATES FOR THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS

    May 1, 2010, 00:00

  • PHP113 A NOVEL APPROACH FOR ESTIMATING RESOURCE UTILIZATION IN PATIENTS WITH SUSPECTED IMMUNE-MEDIATED COAGULOPATHY ASSOCIATED WITH EXPOSURE TO TOPICAL BOVINE THROMBIN

    May 1, 2010, 00:00

  • PMS33 PARTICIPATION, SATISFACTION AND KNOWLEDGE LEVEL AMONG PSORIATIC ARTHRITIS AND CUTANEOUS PSORIASIS PATIENTS

    May 1, 2010, 00:00

  • PCN115 HEAD-TO-HEAD COMPARISONS OF QUALITY OF LIFE INSTRUMENTS FOR YOUNG ADULT SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCER

    May 1, 2010, 00:00

  • PHP39 SENSITIVITY OF MEDICATION USE AND OUTCOMES TO FORMULARY CONTROLS IN THE ELDERLY- A REVIEW OF THE LITERATURE

    May 1, 2010, 00:00

  • PCV116 HEALTH-RELATED QUALITY OF LIFE OF DIABETES PATIENTS WITH AND WITHOUT MACROVASCULAR COMORBIDITIES IN THE UNITED STATES

    May 1, 2010, 00:00

  • PHP91 DRUGS PRESCRIBING INDICATORS IN SECOND AND THIRD-LEVEL COMPLEXITY HOSPITALS FROM COLOMBIA

    May 1, 2010, 00:00

  • PHP3 EFFECTIVENESS OF A PATIENT PERSISTENCY PROGRAM TO INCREASE COMPLIANCE FOR VACCINATION

    May 1, 2010, 00:00

  • PHP76 DRUG POLICY IN SLOVAKIA- IMPACT OF PRICING AND REIMBURSEMENT REFORMS

    May 1, 2010, 00:00

  • PGI19 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PRIVATE PAYER PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PCN16 CANCER INCIDENCE IS INFLUENCED BY INSULIN DOSE AND METFORMIN IN TYPE 2 DIABETES

    May 1, 2010, 00:00

  • PSS5 COST-EFFECTIVENESS STUDY ON THE USE OF TERBINAFINE VS. ITRACONAZOLE IN THE TREATMENT OF ONYCHOMYCOSIS IN MEXICO- AN INSTITUTIONAL PERSPECTIVE BASED ON THE RESULTS OF THE L.I.O.N. STUDY

    May 1, 2010, 00:00

  • PRS12 PULMONARY REHABILITATION- A BUDGET IMPACT MODEL TO EVALUATE HOW POLICY CHANGES WILL IMPACT REIMBURSEMENT FROM A MANAGED CARE PERSPECTIVE

    May 1, 2010, 00:00

  • PMS57 EVIDENCE APPRAISAL FOR THE TREATMENT OF FIBROMYALGIA- COMPENDIA, GUIDELINES, AND A REVIEW OF CLINICAL TRIALS

    May 1, 2010, 00:00

  • PMH80 THE ASSOCIATION BETWEEN TYPE OF ANTIPSYCHOTIC AND RATES OF HOSPITALIZATION AMONG MEDICARE BENEFICIARIES

    May 1, 2010, 00:00

  • PCV121 THE IMPACT OF PART D ON PREVIOUSLY UNINSURED MEDICARE BENEFICIARIES WITH HYPERTENSION

    May 1, 2010, 00:00

  • PMC37 PATIENT REPORTED OUTCOME RECALL PERIODS IN LIGHT OF THE FINAL FDA GUIDANCE

    May 1, 2010, 00:00

  • PIH24 EVALUATION OF THE AMERICAN (U.S.A.) VERSION OF THE ENDOMETRIOSIS HEALTH PROFILE (EHP-30)

    May 1, 2010, 00:00

  • PND39 AGREEMENT BETWEEN MULTIPLE SCLEROSIS-RELATED VARIABLES IN MEDICAL CHARTS AND CLAIMS DATA

    May 1, 2010, 00:00

  • PCN25 THE BUDGETARY IMPACT OF PEMETREXED MAINTENANCE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER

    May 1, 2010, 00:00

  • PCN134 THE ECONOMIC IMPACT OF CONTOUR VERSUS HAND SEWN SUTURE AND OTHER MECHANICAL STAPLES IN LOW ANTERIOR RESECTIONS IN COLON RECTAL CANCER SURGERY- INTERIM RESULTS USING REAL WORLD DATA FROM PREMIERS HOSPITAL DATABASE

    May 1, 2010, 00:00

  • PCN4 INSULINS AND RISK OF CANCER AMONG TYPE 2 DIABETICS- A SYSTEMATIC REVIEW

    May 1, 2010, 00:00

  • PCV146 STATIN USE BEFORE AND AFTER CABG PROCEDURE

    May 1, 2010, 00:00

  • PND12 THE COST-EFFECTIVENESS OF XEOMIN IN CERVICAL DYSTONIA AND BLEPHAROSPASM IN SWEDEN

    May 1, 2010, 00:00

  • PIH7 PREDICTORS OF NON-MEDICAL USE OF PRESCRIPTION DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATES

    May 1, 2010, 00:00

  • PSY57 MAINTENANCE INFLIXIMAB DOSING AND ADMINISTRATION PATTERNS IN PATIENTS WITH CROHNS DISEASE

    May 1, 2010, 00:00

  • PHP8 BENEFICIARY CHOICE IN MEDICARE PART D

    May 1, 2010, 00:00

  • PHP66 EXCESS HOSPITAL COSTS ATTRIBUTABLE TO MEDICATION ERRORS IN HOSPITALIZED PATIENTS

    May 1, 2010, 00:00

  • PDB34 A COST-MINIMIZATION ANALYSIS FOR TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETERMIR IN A BASAL SUPPORTED ORAL THERAPY IN CHINA

    May 1, 2010, 00:00

  • PCN145 A COMPARISON OF PHYSICIAN AND PATIENT DECISION MAKING FOR FIRST VERSUS SECOND OPINIONS AMONG MEN WITH LOCAL STAGE PROSTATE CANCER

    May 1, 2010, 00:00

  • HT3 MULTICRITERIA DECISION ANALYSIS (MCDA) FOR DRUG COVERAGE DECISION BY A PUBLIC HEALTH PLAN- CASE STUDY OF TRAMADOL FOR CHRONIC NON-CANCER PAIN (CNCP) IN CANADA

    May 1, 2010, 00:00

  • PHP102 ADVANCING THE EVIDENCE BASE FOR ORTHOTICS AND PROSTHETICS

    May 1, 2010, 00:00

  • PUK1 INCIDENCE AND COST OF ADVERSE EVENTS (AES) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) TREATED WITH ANGIOGENESIS INHIBITORS (AIS)

    May 1, 2010, 00:00

  • PMS65 DERIVING DOCTORS PRESCRIBING PATTERNS FROM CLAIMS DATA- AN APPLICATION TO TNF AND NON-TNF BIOLOGICS

    May 1, 2010, 00:00

  • PGI37 FACTORS ASSOCIATED WITH THE USE OF ENTERAL AND PARENTERAL PROTON PUMP INHIBITOR USE IN CRITICALLY ILL PATIENTS

    May 1, 2010, 00:00

  • PND23 CONCORDANCE OF SELF-REPORT MEASURES OF DSM-IV-TR, ICD-IO, AND RDC INSOMNIA WITH STANDARDIZED CLINICAL ASSESSMENTS IN THE AMERICA INSOMNIA SURVEY (AIS)

    May 1, 2010, 00:00

  • PUK22 REJECTION EPISODES REQUIRING HOSPITALIZATION AFTER KIDNEY TRANSPLANT IN BRAZIL- A RETROSPECTIVE DATABASE STUDY OF THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2010, 00:00

  • PCV79 COST-EFFECTIVENESS OF DALTEPARIN IN THE MANAGEMENT OF UNSTABLE ANGINA/NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (UA/NSTEMI) EVENTS IN ADULT PATIENTS IN MEXICO

    May 1, 2010, 00:00

  • CM2 EFFECTS OF NONADHERENCE WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS/ANGIOTENSIN RECEPTOR BLOCKERS ON HOSPITALIZATION AND MORTALITY AMONG PATIENTS WITH DIABETES

    May 1, 2010, 00:00

  • PMC10 RATIONALE AND DEVELOPMENT OF AN ONLINE DIRECTORY OF DATABASE PROFILES FOR PHARMACOEPIDEMIOLOGY, OUTCOMES, AND POPULATION RESEARCH

    May 1, 2010, 00:00

  • PCASE4 HOW TO IMPLEMENT NATIONAL ESSENTIAL MEDICINE LIST IN SHANGHAI- PROS CONS

    May 1, 2010, 00:00

  • PMS36 INJECTION SITE REACTION QUESTIONNAIRE- AN ADEQUATE TOOL FOR MEASURING INJECTION SITE REACTIONS?

    May 1, 2010, 00:00

  • PCV30 TARGETING AFRICAN AMERICANS WITH CONGESTIVE HEART FAILURE- THE CASE OF BIDIL

    May 1, 2010, 00:00

  • PMS32 ANTI-TUMOR NECROSIS FACTOR SWITCHING, DISCONTINUATION, AND PERSISTENCE IN MANAGED CARE PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PHP65 USEFFULNESS OF COST PER DEFINED DAILY DOSE (DDD) TO IDENTIFY PROBLEMATIC DRUGS IN MEDIUM- AND HIGH-LEVEL COMPLEXITY HOSPITALS FROM COLOMBIA

    May 1, 2010, 00:00

  • PDB72 POTENTIALLY PREVENTABLE HOSPITALIZATIONS FOR DIABETES COMPLICATIONS, CARE ORGANIZATION AND CONTINUITY OF CARE

    May 1, 2010, 00:00

  • PIN19 A PHARMACOECONOMICS ANALYSIS OF ERTAPENEN VS SEVERAL ANTIBIOTICS USED FOR THE TREATMENT OF COMMUNITY-ACQUIRED INTRA-ABDOMINAL INFECTIONS AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2010, 00:00

  • PMH83 HEALTH CARE EXPENDITURES IN PEDIATRIC POPULATION WITH DEPRESSION IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCV7 INCIDENCE AND OUTCOMES OF POTENTIAL DRUG-DRUG INTERACTIONS BETWEEN ACE/ARB AND POTASIUM SPARING DIURETICS

    May 1, 2010, 00:00

  • PSY58 US COST EFFECTIVENESS ANALYSIS OF PRIMARY PROPHYLAXIS VERSUS ON-DEMAND TREATMENT IN HEMOPHILIA- DESIGN AND RATIONALE OF A COMPREHENSIVE MODEL

    May 1, 2010, 00:00

  • PMH1 SIDE EFFECTS ASSOCIATED WITH PRESCRIPTION OF METHYLPHENIDATE IN TAIAWN

    May 1, 2010, 00:00

  • PND14 COST-UTILITY ANALYSIS ON HYPOTHETICAL NEUROIMAGING TRACER FOR DIAGNOSIS OF DEMENTIA OF ALZHEIMER TYPE IN JAPAN

    May 1, 2010, 00:00

  • PMS4 CHARACTERIZING UNCERTAINTY IN EARLY-DEVELOPMENT BUDGETARY IMPACT MODELS- A CASE STUDY OF DENOSUMAB

    May 1, 2010, 00:00

  • PHP16 LOW SOCIOECONOMIC STATUS IS A RISK FACTOR FOR CPAP ACCEPTANCE AMONG ADULT OSAS PATIENTS REQUIRING TREATMENT

    May 1, 2010, 00:00

  • PMH43 DECLINE IN THE RATE AND COST OF PSYCHIATRIC HOSPITALIZATION FOLLOWING INITIATION OF DEPOT ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PCN63 THE COST-EFFECTIVENESS OF MOHS MICROGRAPHIC SURGERY VERSUS SURGICAL EXCISION FOR THE TREATMENT OF NONMELANOMA SKIN CANCER

    May 1, 2010, 00:00

  • PUK26 THE NON-LINEAR RELATIONSHIP BETWEEN DOSING FREQUENCY AND BREAK-EVEN COSTS IN CAPITATED ESRD REIMBURSEMENT

    May 1, 2010, 00:00

  • PCN17 CASTRATION-RESISTANT PROSTATE CANCER (CRPC)- A UK EPIDEMIOLOGY STUDY

    May 1, 2010, 00:00

  • PMS49 TRENDS IN THE PRESCRIBING OF CONVENTIONAL ANTIRHEUMATIC THERAPY AMONG CANADIANS WITH RHEUMATOID ARTHRITIS- A RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PHP45 COMPARISONS OF EMPLOYEE WORKERS COMPENSATION COSTS AND ABSENCE DAYS USING A NATIONAL DATABASE

    May 1, 2010, 00:00

  • PCN123 PREVALENCE AND CORRELATES OF HUMAN PAPILLOMAVIRUS VACCINATION IN ADOLESCENT GIRLS- RESULTS FROM NATIONAL SURVEY OF CHILDRENS HEALTH

    May 1, 2010, 00:00

  • PMH37 CHARACTERISTICS OF HOSPITALIZATIONS FOR ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER (ADHD) AMONG CHILDREN AND ADOLESCENTS IN THE UNITED STATES FROM 2000-2006

    May 1, 2010, 00:00

  • PUK10 IMPROVED RESOURCE UTILIZATION OUTCOMES ASSOCIATED WITH PREDIALYSIS USE OF PARICALCITOL FOR SECONDARY HYPERPARATHYROIDISM (SHPT)

    May 1, 2010, 00:00

  • PHP59 PHARMACY BENEFIT INTEGRATION AND ADHERENCE TO EVIDENCE-BASED MEDICINE IN A COMMERCIALLY-INSURED POPULATION

    May 1, 2010, 00:00

  • PMH62 DISRUPTIONS IN ANTIPSYCHOTIC ADHERENCE ARE JOINTLY RELATED WITH REDUCED ADHERENCE FOR OTHER CHRONIC CONDITIONS

    May 1, 2010, 00:00

  • PCN1 USE OF WHITE BLOOD CELL GROWTH FACTORS AND RISK OF ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES AMONG ELDERLY NON-HODGKINS LYMPHOMA PATIENTS

    May 1, 2010, 00:00

  • PUK9 SEVEN YEAR TRENDS OF PHARMACY BENEFIT ERYTHROPOIESIS-STIMULATING AGENT UTILIZATION AND COST CONSIDERATIONS OF CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS

    May 1, 2010, 00:00

  • PCN79 REVIEW OF COST-EFFECTIVENESS STUDIES ON AROMATASE INHIBITORS FOR THE TREATMENT OF EARLY-STAGE BREAST CANCER

    May 1, 2010, 00:00

  • PIN35 ECONOMIC EVALUATION OF CEFTOBIPROLE FOR THE TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PSY33 OPIOID USE AND COSTS IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY TREATED WITH PREGABALIN OR STAN DARD-OF-CARE

    May 1, 2010, 00:00

  • PHP106 THE HEALTH ECONOMIC IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN THE COMMUNITY SETTING IN THE NETHERLANDS

    May 1, 2010, 00:00

  • PDB52 ATTEMPTED WEIGHT LOSS OR REGULAR EXERCISE- IMPACT ON QUALITY OF LIFE AMONG ADULTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS

    May 1, 2010, 00:00

  • PMS16 ANALYSIS OF DIAGNOSES RELATED GROUP NUMBER 234-OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE-OPERATING ROOM PROCEDURES

    May 1, 2010, 00:00

  • PIN47 FEASIBILITY STUDY OF A NOVEL METHOD TO QUANTIFY SURGICAL INTERVENTIONS IN PATIENTS WITH COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS (CSSSl) USING HOSPITAL ELECTRONIC HEALTH RECORD DATA

    May 1, 2010, 00:00

  • PND11 HEALTH ECONOMIC IMPACT OF EARLY TREATMENT OF MULTIPLE SCLEROSIS WITH DISEASE MODIFYING THERAPY

    May 1, 2010, 00:00

  • PHP82 PHARMACISTS PERSPECTIVE ON RECENT LABELING CHANGES REQUIRED BY FDA FOR OVER-THE-COUNTER INTERNAL ANALGESIC, ANTIPYRETIC AND ANTIRHEUMATIC DRUGS

    May 1, 2010, 00:00

  • PCV84 COST-EFFECTIVENESS OF ROSUVASTATIN 10 MG IN THE REDUCTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS AT RISK OF CARDIOVASCULAR DISEASE

    May 1, 2010, 00:00

  • PND8 APPROACH TO MATCHING ALZHEIMERS DISEASE PATIENTS AND THEIR SPOUSES TO ASSESS CAREGIVER BURDEN IN AN ADMINISTRATIVE CLAIMS DATABASE

    May 1, 2010, 00:00

  • PIN5 A BUDGET IMPACT ANALYSIS OF THREE PRESURGICAL SKIN ANTISEPSIS PROTOCOLS

    May 1, 2010, 00:00

  • PRS25 ALBUTEROL AND LEVALBUTEROL USE AND SPENDING IN MEDICARE BENEFICIARIES WITH COPD

    May 1, 2010, 00:00

  • PMS19 REAL-WORLD USE OF DULOXETINE FOR LOW BACK PAIN AND CHRONIC LOW BACK PAIN- TREATMENT PATTERN, DIRECT AND INDIRECT COSTS

    May 1, 2010, 00:00

  • PCN113 HEALTH RELATED QUALITY OF LIFE, FEAR OF RECURRENCE, IMPACT OF EVENTS, ILLNESS INTRUSIVENESS AND PSYHOLOGICAL DISTRESS IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

    May 1, 2010, 00:00

  • PMS41 MANAGEMENT OF KNEE OSTEOARTHRITIS- IMPACT ON PAIN ON A DAILY BASIS

    May 1, 2010, 00:00

  • PCN160 PATIENT-REPORTED OUTCOMES SUPPORTING ONCOLOGY PRODUCT LABELING CLAIMS- TRENDS AND CHALLENGES

    May 1, 2010, 00:00

  • PHP40 IMPORTANCE OF CONSIDERING THE TREATMENT COMPLEMENTARITY OF MEDICINES IN DESIGNING PHARMACEUTICAL BENEFITS

    May 1, 2010, 00:00

  • PHP88 EVIDENCE USED DURING PHARMACEUTICAL TECHNOLOGY ASSESSMENT

    May 1, 2010, 00:00

  • PCN151 CLINICAL AND SOCIO-DEMOGRAPHIC DETERMINANTS OF PRIMARY PROPHYLACTIC G-CSF USE IN ELDERLY BREAST CANCER MEDICARE BENEFICIARIES RECEIVING CHEMOTHERAPY

    May 1, 2010, 00:00

  • PSY50 DISPARITY IN THE MANAGEMENT OF OBESITY IN AMBULATORY SETTING- A NAMCS 2006-07 ANALYSIS

    May 1, 2010, 00:00

  • TR4 PUBLIC HEALTH AND ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN AN INFLUENZA PANDEMIC IN SINGAPORE AND HONG KONG

    May 1, 2010, 00:00

  • PCN94 COST-MINIMIZATION ANALYSIS OF BIOPSY-BASED RISK STRATIFICATION TOOLS IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS

    May 1, 2010, 00:00

  • PIN17 COST-EFFECTIVE ANALYSIS OF BEHAVIORAL INTERVENTIONS UTILIZING MEMS FOR ANTIRETROVIRAL MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PMS14 CHARACTERIZING LOST PRODUCTIVITY AND DIRECT AND INDIRECT COSTS OF RHEUMATOID ARTHRITIS-A LARGE, SELF-INSURED EMPLOYERS PERSPECTIVE

    May 1, 2010, 00:00

  • PIH11 THE BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) ON PATIENTS HOSPITALIZED WITH A PRIMARY DIAGNOSIS OF OPPOSITIONAL DEFIANT DISORDER (ODD)

    May 1, 2010, 00:00

  • PCV44 BUDGET IMPACT OF BIVALIRUDIN IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) IN ITALIAN HOSPITALS

    May 1, 2010, 00:00

  • PCV149 QUALITY OF PHARMACEUTICAL CARE PROVIDED IN A CHRONIC DISEASE- GEOGRAPHIC VARIATION, PROCESS OF CARE MEASURES AND CLINICAL OUTCOMES

    May 1, 2010, 00:00

  • PUK28 ASSESSMENT OF RECENT ERYTHROPOIESIS-STIMULATING AGENT GUIDELINES CHANGES ON DOSING PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS

    May 1, 2010, 00:00

  • PCV62 ONE-YEAR CLINICAL AND ECONOMIC OUTCOMES EVALUATION OF PTCA WITH STENTING

    May 1, 2010, 00:00

  • PND25 REFINING THE MEASUREMENT OF MOTOR AND NON-MOTOR SYMPTOMS IN PARKINSONS DISEASE PATIENTS WITH FLUCTUATING SYMPTOMS

    May 1, 2010, 00:00

  • PCN110 HOW MUCH DO PATIENTS WITH RENAL CELL CARCINOMA (RCC) VALUE PROGRESSION FREE SURVIVAL IN MEDICAL DECISION MAKING?-RESULTS FROM A BENEFIT-RISK CONJOINT STUDY

    May 1, 2010, 00:00

  • PMC20 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE EQ-5D VISUAL ANALOGUE SCALE (VAS)

    May 1, 2010, 00:00

  • PCV65 AN EXPLORATORY COST-CONSEQUENCE AND BUDGET IMPACT ANALYSIS OF SIROLIMUS-ELUTING STENT VS. PACLITAXEL-ELUTING STENT- THE IMPACT OF RESTENOSIS AFTER DRUG-ELUTING STENT PLACEMENT UNDER THE PRIVATE PAYERS PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PGI9 A BUDGET IMPACT MODEL TO EVALUATE MEDICATION PERSISTENCE AND ASSOCIATED HEALTH CARE COSTS

    May 1, 2010, 00:00

  • HE2 HEALTH CARE COSTS OF METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD AND NECK-FINDINGS FROM LINKED SEER-MEDICARE DATA

    May 1, 2010, 00:00

  • PSS14 VALIDATION OF THE EYELASH SATISFACTION FOLLOW-UP QUESTIONNAIRE FOR FOLLOW-UP SELF-ASSESSMENT OF EYELASH SATISFACTION

    May 1, 2010, 00:00

  • PGI23 COST EFFECTIVENESS ANALYSIS OF RIFAXIMIN FOR THE TREATMENT OF ACUTE HEPATIC ENCEPHALOPATHY

    May 1, 2010, 00:00

  • PMS40 CREATION OF A SHORT VERSION OF THE VALUED LIFE ACTIVITIES QUESTIONNAIRE (S-VLA)

    May 1, 2010, 00:00

  • PIN27 COST-EFFECTIVENESS ANALYSIS OF THE THERAPY FOR THE INVASIVE ASPERGILOSIS IN COLOMBIA

    May 1, 2010, 00:00

  • PMS64 PROJECTION OF SURGICAL LOADS OF HIP AND KNEE ARTHROPLASTY IN GERMANY

    May 1, 2010, 00:00

  • PCN23 OVERALL SURVIVAL AND GAP IN DOCETAXEL TREATMENT CONTINUATION IN PATIENTS WITH METASTATIC PROSTATE CANCER - RESULTS FROM A US ONCOLOGY NETWORK

    May 1, 2010, 00:00

  • PCV105 UNDERSTANDING BARRIERS TO MEDICATION ADHERENCE FOR THE

    May 1, 2010, 00:00

  • PMH71 ISSUES IN THE USE OF THE HOSPITAL ANXIETY AND DEPRESSION SCALE IN AN ALCOHOL-DEPENDENT POPULATION

    May 1, 2010, 00:00

  • PMS59 A RETROSPECTIVE STUDY OF INCIDENCE, PREVALENCE, TREATMENT PATTERNS AND COST OF RHEUMATOID ARTHRITISS IN TAIWAN USING THE NATIONAL HEALTH INSURANCE DATA

    May 1, 2010, 00:00

  • RM3 RISK OF FALLS AND FRACTURES IN OLDER ADULTS USING ATIPSYCHOTIC AGENTS- A PROPENSITY-MATCHED RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PGI21 ECONOMIC ANALYSIS OF ALVIMOPAN FOR PREVENTION AND MANAGEMENT OF POST-OPERATIVE ILEUS

    May 1, 2010, 00:00

  • PMC31 THE ROLE OF THE PATIENT VOICE IN HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2010, 00:00

  • PGI17 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PCV14 COMPARATIVE EFFECTIVENESS ANALYSIS IDENTIFIES A SUPERIOR POINT OF CARE DEVICE FOR ASSESSING THE INTERNATIONAL NORMALIZED RATIO

    May 1, 2010, 00:00

  • PMS48 HYALURONIC ACID MANAGEMENT OF KNEE OSTEOARTHRITIS- IMPACT ON PAIN

    May 1, 2010, 00:00

  • PCV97 ANALYSIS ON THE EFFECTS OF MEDICARE PART D COVERAGE GAP ON STATIN MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PND7 THE IMPACT OF SPECIALTY PHARMACY PARTICIPATION ON HEALTH CARE COSTS IN A MULTIPLE SCLEROSIS POPULATION USING BIOLOGIC DMD THERAPY

    May 1, 2010, 00:00

  • PCV133 THE COST-EFFECTIVENESS OF GENOTYPING CYP2C19 TO GUIDE ANTIPLATELET THERAPY SELECTION

    May 1, 2010, 00:00

  • PHP28 EPISODES OF CARE AND INPATIENT MORTALITY FOLLOWING POISONINGS FROM OVER-THE-COUNTER MEDICATIONS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PGI32 CORRESPONDENCE OF MULTIPLE HEALTH OUTCOMES MEASURES IN RESPONSIVENESS TO MMX MESALAMINE TREATMENT FOR PATIENTS WITH ULCERATIVE COLITIS

    May 1, 2010, 00:00

  • PDB31 REDUCED LONG-TERM COSTS AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS INITIATED ON RAPID-ACTING INSULIN ASPART COMPARED WITH HUMAN INSULIN

    May 1, 2010, 00:00

  • PDB26 MODELLING COST EFFECTIVENESS OF BEHAVIOUR MODIFICATION PROGRAMMES AND EFFECTS ON MEDICATION- CASE STUDY OF EDUCATION PROGRAMMES IN DIABETES

    May 1, 2010, 00:00

  • PCN102 EFFECTS OF VA ONCWATCH INTERVENTION ON COLORECTAL CANCER SCREENING ADHERENCE

    May 1, 2010, 00:00

  • PHP92 HEALTH CARE PROFESSIONAL STUDENTS KNOWLEDGE OF DRUG-DRUG INTERACTIONS- A PRETEST POSTTEST STUDY

    May 1, 2010, 00:00

  • PMH20 USE OF A LINKED HOSPITAL ADMISSIONS AND HEALTH CARE CLAIMS DATABASE IN PHARMACEUTICAL OUTCOMES RESEARCH- RESULTS OF A FEASIBILITY STUDY EXAMINING TREATMENT OF SCHIZOPHRENIA WITH ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PDB15 ECONOMIC OUTCOMES OF THREE INSULIN THERAPY PROTOCOLS IMPLEMENTED IN A SURGICAL INTENSIVE CARE UNIT

    May 1, 2010, 00:00

  • PSY43 A COMPARISON OF PHYSICIAN-PRESCRIBED AND PATIENT/ CAREGIVER REPORTED DOSING OF RECOMBINANT FACTOR VII (RFVIIA)- HOME TREATMENT OF ACUTE BLEEDS IN THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)

    May 1, 2010, 00:00

  • PIH8 DOES TRIAL PARTICIPATION IMPACT ON THE PSYCHOMETRIC PROPERTIES OF SELF-REPORT DEPRESSION IN POSTNATAL WOMEN?

    May 1, 2010, 00:00

  • PIN30 CLINICAL AND ECONOMIC IMPACT OF I 3-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN SINGAPORE AND HONG KONG

    May 1, 2010, 00:00

  • PSY24 COST-EFFECTIVENESS OF HAEMATE P PROPHYLACTIC TREATMENT FOR BLEEDING EPISODES IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE

    May 1, 2010, 00:00

  • PGI28 UTILIZATION AND COST OF PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN THE MANAGEMENT OF CHRONIC HEPATITIS C VIRUS IN EUROPE

    May 1, 2010, 00:00

  • PHP78 UNDERSTANDING DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE COMMON DRUG REVIEW (CDR)

    May 1, 2010, 00:00

  • PMH11 DISCRETE EVENT SIMULATION MODEL IN MAJOR DEPRESSIVE DISORDER- LIFE-TIME HEALTH OUTCOMES OF ADJUNCTIVE ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PMH57 PSYCHIATRIC-RELATED HEALTH CARE COSTS AND RISK OF HOSPITALIZATION AMONG MEDICAID PATIENTS WITH TYPE I BIPOLAR DISORDER WHO RELAPSE FREQUENTLY

    May 1, 2010, 00:00

  • PCN56 COSTS ASSOCIATED TO THE TREATMENT OF DIFFERENT STAGES OF MEXICAN BREAST CANCER PATIENTS

    May 1, 2010, 00:00

  • SB2 COMPARING BINARY PROPENSITY SCORE ANALYSIS WITH MULTIPLE PROPENSITY SCORE APPROACH AMONG PATIENTS WITH CHRONIC HEART FAILURE

    May 1, 2010, 00:00

  • PRS37 DRUG UTILIZATION PATTERNS FOR PEDIATRIC ASTHMA IN AMBULATORY CARE SETTINGS

    May 1, 2010, 00:00

  • PM4 TRANSLATIONAL AND POLICY RESEARCH IN PERSONALIZED MEDICINE FOR CANCER

    May 1, 2010, 00:00

  • PHP20 PSYCHOTROPIC DRUG UTILIZATION PATTERNS AMONG ELDERLY NURSING HOME RESIDENTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PMC43 EIGHT KEY EVIDENCES FOR CONTENT VALIDITY OF PATIENT REPORTED OUTCOME (PRO) INSTRUMENTS

    May 1, 2010, 00:00

  • PCN78 COST-EFFECTIVENESS MODELLING OF EPOETIN ALFA AND DARBEPOETIN ALFA IN THE TREATMENT OF CHEMOTHERAPYRELATED ANAEMIA IN SWEDEN

    May 1, 2010, 00:00

  • PMH90 WEB-SURVEYS- REAL WORLD EVIDENCE GATHERING AND MINIMIZING UNCERTAINTY IN ECONOMIC MODELS

    May 1, 2010, 00:00

  • PCN149 ELECTRONIC MEDICAL RECORDS- QUALITY CANCER CARE AND COST-EFFECTIVENESS

    May 1, 2010, 00:00

  • PSY42 ASSOCIATION BETWEEN SELF-REPORTED NEUROPATHIC PAIN SEVERITY AND THE EQ-5D IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) OR POST-HERPETIC NEURALGIA (PHN)

    May 1, 2010, 00:00

  • PDB43 ADHERENCE AND PERSISTENCE AMONG TYPE II DIABETIC PATIENTS STARTING MONOTHERAPY ON ORAL HYPOGLYCEMIC AGENTS

    May 1, 2010, 00:00

  • PHP27 TRENDS IN EMERGENCY DEPARTMENT VISITS DUE TO OPIOID ABUSE IN THE UNITED STATES, 1996-2007

    May 1, 2010, 00:00

  • PCV32 RISK FACTORS ASSOCIATED WITH PREVALENCE OF HYPERTENSION- EVIDENCE FROM THE 2007 KOREA NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (K-NHANES)

    May 1, 2010, 00:00

  • PSY21 PROJECTING THE ECONOMIC OUTCOMES OF OBESITY USING A NATURAL HISTORY MODEL

    May 1, 2010, 00:00

  • PMH35 COMPARATIVE EFFECTIVENESS OF LONG-ACTING RISPERIDONE- A REPORT OF RESOURCE UTILISATION AND COSTS IN A 12 MONTH MIRROR-IMAGE ANALYSIS

    May 1, 2010, 00:00

  • PCV117 QUALITY OF LIFE OF PATIENTS WITH HYPERTENSION USING THE 2007 NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES) OF KOREA

    May 1, 2010, 00:00

  • PHP24 THE PRESCRIPTION DRUG BURDEN FOR US ADULTS BETWEEN THE AGES OF 55 TO 64

    May 1, 2010, 00:00

  • PCV153 FAILURE OF THE BLAND-ALTMAN METHOD TO IDENTIFY CLINICALLY IMPORTANT DISAGREEMENT BETWEEN MEASURES OF THE INTERNATIONAL NORMALIZED RATIO

    May 1, 2010, 00:00

  • PMS2 ESTIMATING HEALTH-RELATED UTILITY FROM CLINICALLY ASSESSED DISEASE SEVERITY IN ANKYLOSING SPONDYLITIS

    May 1, 2010, 00:00

  • PHP84 OUTCOMES OF BEDSIDE-BARCODE TECHNOLOGY INTERVENTION ON MEDICATION ADMINISTRATION TIME IN AN INTENSIVE CARE UNIT

    May 1, 2010, 00:00

  • PCN96 A TRIAL-BASED ASSESSMENT OF THE COST-UTILITY OF BEVACIZUMAB AND CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2010, 00:00

  • PCN57 COSTS ASSOCIATED TO THE TREATMENT OF DIFFERENT STAGES OF MEXICAN PATIENTS WITH COLORECTAL CANCER

    May 1, 2010, 00:00

  • PMH12 THE COMPARATIVE EFFICACY OF INJECTABLE AND ORAL ATYPICAL ANTIPSYCHOTICS IN REDUCING RELAPSES IN ADULT SCHIZOPHRENIA PATIENTS- A SYSTEMATIC REVIEW AND MIXED TREATMENT COMPARISON ANALYSIS

    May 1, 2010, 00:00

  • PHP21 SOURCES OF MEDICATION FOR PATIENTS IN GENERAL MEDICINE

    May 1, 2010, 00:00

  • PSY40 EXTENDED-RELEASE OXYMORPHONE IS ASSOCIATED WITH LOWER SUBJECTIVE MONETARY VALUE THAN CONTROLLED-RELEASE OXYCODONE IN NONDEPENDENT RECREATIONAL OPIOID USERS

    May 1, 2010, 00:00

  • PCN111 PRO LABELLING CLAIMS IN ANTINEOPLASTIC AGENTS

    May 1, 2010, 00:00

  • PSY34 OBESITY AND HEALTH CARE COSTS AND UTILIZATION IN THE VETERAN AFFAIRS POPULATION

    May 1, 2010, 00:00

  • PIH10 TREATMENT PATTERNS AND ECONOMIC BURDEN OF UTERINE FIBROIDS IN A UNITED STATES MANAGED CARE DATABASE

    May 1, 2010, 00:00

  • PCV25 PERCUTANEOUS CORONARY INTERVENTION COMPARED WITH AORTOCORONARY BYPASS IN DIABETIC PATIENTS WITH MULTIVASCULAR CORONARY DISEASE

    May 1, 2010, 00:00

  • PCN58 BEVACIZUMAB FOR THE TREATMENT OF METASTATIC BREAST CANCER- A COST-EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • PUK16 COST-EFFECTIVENESS ANALYSIS IN TREATING OVERACTIVE BLADDER WITH URGE INCONTINENCE IN WOMEN- A COMPARISON BETWEEN OXYBUTYNIN AND TOLTERODINE WITH EXPLORATORY ANALYSIS OF FESOTERODINE

    May 1, 2010, 00:00

  • PGI11 PEDIATRIC HOSPITALIZATIONS FOR INFLAMMATORY BOWEL DISEASE- RESULTS FROM 2006 KIDS INPATIENT DATABASE

    May 1, 2010, 00:00

  • PMH13 CHARACTERISTICS AND COST OUTCOMES OF INSURED PATIENTS TREATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) OR ORAL ALCOHOL DEPENDENCE MEDICATIONS

    May 1, 2010, 00:00

  • PCN93 COST-EFFECTIVENESS ANALYSIS OF BENDAMUSTINE COMPARED TO ALEMTUZUMAB AND CHLORAMBUCIL FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN A TREATMENT-NAIVE POPULATION

    May 1, 2010, 00:00

  • PIN32 COST-EFFECTIVENESS OF 2009 PANDEMIC INFLUENZA A(H I N I) VACCINATION IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCV110 DISCRIMINATORY POWER OF THE KCCQ IN ESTIMATING HEALTH UTILITIES IN HEART FAILURE PATIENTS

    May 1, 2010, 00:00

  • PDB13 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 (T2D) PATIENTS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

    May 1, 2010, 00:00

  • PCV31 DECLINING ISCHEMIC STROKE-RELATED INPATIENT UTILIZATION- RECENT TRENDS ANALYSIS OF UNITED STATES NATIONAL DATA 2000-2005

    May 1, 2010, 00:00

  • PRS45 INTEGRATED EDUCATIONAL PROJECT WITH INDIVIDUAL FEEDBACK FROM CLAIMS DATA LEADS TO IMPROVED ANTIBIOTIC PRESCRIPTION AND RESISTANCE DECREASE

    May 1, 2010, 00:00

  • PMH25 ASSESSMENT OF HOSPITALIZATION RISK AMONG PATIENTS WITH BIPOLAR I DISORDER TREATED WITH ANTIPSYCHOTIC THERAPY IN A COMMERCIALLY INSURED POPULATION

    May 1, 2010, 00:00

  • PCV82 ECONOMIC EVALUATION OF THE USE OF PERFLUOROCARBON EMULSION (PFC) VS. PERIOPERATIVE BLOOD TRANSFUSION IN CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS AT THE MEXICAN INSTITUTE OF SOCIAL SECURITY

    May 1, 2010, 00:00

  • PCN60 COST-EFFECTIVENESS OF OXALIPLATIN AND IRINOTECAN BASED COMBINATION THERAPY COMPARED WITH 5FU/LV FOR THE TREATMENT OF US ELDERLY ADVANCED COLON CANCER PATIENTS

    May 1, 2010, 00:00

  • PMS22 THE COST-EFFECTIVENESS OF PREGABALIN (LYRICA) IN THE TREATMENT OF SEVERE FIBROMYALGIA IN THE UNITED STATES

    May 1, 2010, 00:00

  • PMH22 THE IMPACT OF OUTPATIENT MENTAL HEALTH SERVICES ON RE-ARRESTS AMONG GROUPS OF INDIVIDUALS WITH A SERIOUS MENTAL ILLNESS IN TWO URBAN COUNTIES, ONE IN FLORIDA AND ONE IN TEXAS

    May 1, 2010, 00:00

  • PRS8 RISK OF SERIOUS ASTHMA EXACERBATION AND SPIROMETRY TEST IN CHILDREN

    May 1, 2010, 00:00

  • PGI29 SELECTING CHRONIC CONSTIPATION (CC) CLINICAL TRIAL ENDPOINTS- INCORPORATING THE PATIENTS VOICE

    May 1, 2010, 00:00

  • PCV76 SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF SELECTED CARDIAC IMAGING TECHNOLOGIES IN THE DIAGNOSIS OF CORONARY ARTERY DISEASE

    May 1, 2010, 00:00

  • PCV112 RESPONSIVENESS OF AF6, A NEW, SHORT, VALIDATED, AF-SPECIFIC QUESTIONNAIRE-SYMPTOMTIC BENEFIT OF DC CARDIOVERSION

    May 1, 2010, 00:00

  • PCV71 COST-EFFECTIVENESS OF 123I-MIBG (ADREVIEW) IMAGING FOR PATIENT TREATMENT SELECTION IN THE PREVENTION OF SUDDEN CARDIAC DEATH

    May 1, 2010, 00:00

  • PRS30 HEALTH CARE RESOURCE USE AND TIME TO DIAGNOSIS ATTRIBUTABLE TO MANAGING COW MILK ALLERGY IN THE USA- CURRENT ESTIMATES AND PREDICTED EFFECTS OF LEGISLATION THAT REQUIRES HEALTH CARE COVERAGE FOR AMINO ACID FORMULAS

    May 1, 2010, 00:00

  • PDB63 COMPARATIVE RESULTS ON EFFECTS OF TYPES OF INSURANCE AND PAYMENT PLANS ON PHYSICIANS COST AWARENESS DURING THE PHYSICIAN VISIT USING THE NAMCS SURVEY IN 1996 AND 2005

    May 1, 2010, 00:00

  • PCV18 COST-UTILITY ANALYSIS OF TWO KINDS OF THERAPY FOR ACUTE ISCHEMIC STROKE

    May 1, 2010, 00:00

  • PCV123 DRUG UTILIZATION REVIEW OF DUAL ANTIPLATELET THERAPY AMONG TAIWANESE OLDER ADULTS

    May 1, 2010, 00:00

  • PCASE1 UTILIZING EVIDENCE FROM DIFFERENT LEVELS IN THE REIMBURSEMENT PROCESS OF NEW MEDICAL TECHNOLOGIES-ADVANCED RENAL CELL CARCINOMA FIRST LINE THERAPY IN POLAND 2008-2009

    May 1, 2010, 00:00

  • PCV64 IMPACT OF WORSENING RENAL FUNCTION ON HEALTH CARE UTILIZATION OBSERVED AMONG HOSPITALIZED HEART FAILURE PATIENTS

    May 1, 2010, 00:00

  • PND34 UTILIZATION, PRICE, AND EXPENDITURE TRENDS FOR ANTI-MIGRAINE DRUGS IN THE US MEDICAID PROGRAM FROM 1991 THROUGH 2008

    May 1, 2010, 00:00

  • PRS20 THE ECONOMIC BURDEN OF CHRONIC DISEASES IN ADULT US WORKERS IN TERMS OF MEDICAL EXPENDITURE AND LOST PRODUCTIVITY COSTS

    May 1, 2010, 00:00

  • PR3 NATIONAL CULTURE AND EQ-5D VALUE SETS

    May 1, 2010, 00:00

  • PMC47 STATISTICAL METHODS NEEDED IN HEALTH ECONOMICS

    May 1, 2010, 00:00

  • DB3 MUCH ADO ABOUT THE LACK OF SOCIO-ECONOMIC COVARIATES IN ADMINISTRATIVE CLAIMS DATA

    May 1, 2010, 00:00

  • PCN31 COST COMPARISON OF INPATIENT AND OUTPATIENT HOSPITALBASED SERVICES BETWEEN TWO STRATEGIES FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN A PUBLICLY FUNDED HEALTH CARE SYSTEM

    May 1, 2010, 00:00

  • PSY36 CORRELATES OF ADHERENCE TO IMMUNOSUPPRESSANT MEDICATIONS IN COMMUNITY DWELLING SOLID ORGAN TRANSPLANT RECIPIENTS

    May 1, 2010, 00:00

  • PHP26 THE IMPACT OF MISUSE OF ANTIBIOTIC THERAPIES ON INPATIENT COSTS

    May 1, 2010, 00:00

  • PMC23 A UNIVERSAL SCORING SYSTEM FOR EQ-5D - A VASTLY SIMPLER SOLUTION

    May 1, 2010, 00:00

  • PCN92 VALUATION OF CLINICO-ECONOMIC EFFECTIVNESS OF THEATMENT OF CHILDREN WITH THE NON-HODGKIN LYMPHOMAS (NHLS) ACCORDING TO THE NHL-BFM-95 PROTOCOL

    May 1, 2010, 00:00

  • PMH74 INTENSIVE COGNITIVE INTERVIEWING WITH PATIENTS DIAGNOSED WITH SCHIZOPHRENIA AND THE REFINEMENT OF THE CLEAR THINKING SCALE (CTS)

    May 1, 2010, 00:00

  • PCV141 UTILIZATIONAND EXPENDITURE TRENDS FOR BOTH ANGIOTENSINCONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN THE MEDICAID PROGRAM

    May 1, 2010, 00:00

  • PCV59 EXPLORING THE RELATIONSHIP OF COST SHARING AND FIXED-DOSE COMBINATION VERSUS MONO ANTIHYPERTENSIVE MEDICATION THERAPY AMONG HYPERTENSION PATIENTS

    May 1, 2010, 00:00

  • PUK17 THE VALUE OF HYPERTENSION CONTROL TO CHRONIC KIDNEY DISEASE PREVENTION

    May 1, 2010, 00:00

  • PIH9 TRENDS IN IUD INSERTIONS AND RELATED MEDICAL EXPENDITURE IN THE UNITED STATES- THE POPULATION WITH EMPLOYERSPONSORED INSURANCE

    May 1, 2010, 00:00

  • PCV119 MANAGEMENT OF ACUTE ISCHEMIC STROKE IN THE USA

    May 1, 2010, 00:00

  • PCN40 RETROSPECTIVE COST AND OUTCOME ANALYSIS OF BREAST CANCER PATIENTS TREATED IN A BRAZILIAN OUTPATIENT CANCER CENTER (OCC)

    May 1, 2010, 00:00

  • PDB9 DIABETES RISK ASSESSMENT-APPLICATION AND VALIDATION OF A DIABETES SCREENING SCORE APPLIED TO THE NATIONAL HEALTH AND WELLNESS SURVEY

    May 1, 2010, 00:00

  • PCN66 OPEN VERSUS LAPAROSCOPIC PROCEDURES FOR COLECTOMY SURGERY FOR PATIENTS WITH COLON RECTAL CANCER- A COST EFFECTIVENESS ANALYSIS, UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    May 1, 2010, 00:00

  • PSS12 MODELING THE COST-EFFECTIVENESS OF USTEKINUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN US

    May 1, 2010, 00:00

  • PRS31 RELATIONSHIP BETWEEN DAILY DOSING FREQUENCY, COMPLIANCE, HEALTH CARE RESOURCE USE, AND COSTS- EVIDENCE FROM THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

    May 1, 2010, 00:00

  • PCV93 DISCRETE EVENT SIMULATION OF CARDIAC HOSPITALS PERFORMING PERCUTANEOUS CORONARY INTERVENTIONS

    May 1, 2010, 00:00

  • PSY54 NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) PRESCRIPTION USE FOR MUSCULOSKELETAL PAIN AT FOUR PRIMARY CARE CENTERS IN SWEDEN

    May 1, 2010, 00:00

  • PCV152 TREATMENT PATTERNS, RESOURCE UTILIZATION AND COSTS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE US

    May 1, 2010, 00:00

  • PUK12 ECONOMIC EVALUATION ON THE USE OF OXYBUTYNIN, TOLTERODINE, AND SOLIFENACIN IN PATIENTS WITH HYPERACTIVE BLADDER

    May 1, 2010, 00:00

  • PND10 THE AMERICA INSOMNIA SURVEY (AIS)- AN EPIDEMIOLOGY STUDY OF INSOMNIA PREVALENCE AND BURDEN IN A REPRESENTATIVE POPULATION

    May 1, 2010, 00:00

  • PMS62 DIFFERENCES IN DEMOGRAPHICS AND PRE-INDEX HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TAKING ANTI-TNF BIOLOGICS DURING THE FIRST YEAR OF PERSISTENT THERAPY

    May 1, 2010, 00:00

  • PSS16 SUSTAINED IMPROVEMENT IN SKIN DISEASE-SPECIFIC QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS RECEIVING USTEKINUMAB MAINTENANCE THERAPY- LONG TERM RESULTS FROM PHOENIX 1

    May 1, 2010, 00:00

  • PDB23 RESOURCE CONSUMPTION AND COSTS OF CARE THE YEAR BEFORE AND AFTER INITIATION OF INSULIN THERAPY IN SWEDISH PATIENTS WITH TYPE 2 DIABETES

    May 1, 2010, 00:00

  • PM3 ECONOMIC EVALUATION OF GENETIC TEST IN COMBINATION WITH PREVENTIVE DONEPEZIL TREATMENT FOR AMNESTIC MILD COGNITIVE IMPAIRMENT PATIENTS- LIFE- TIME MODEL

    May 1, 2010, 00:00

  • PCN14 SYSTEMATIC REVIEW OF EFFICACY OUTCOMES REPORTED IN RANDOMISED CONTROLLED TRIALS OF FIRST-LINE (1L) THERAPIES FOR METASTATIC BREAST CANCER (MBC)

    May 1, 2010, 00:00

  • PMS70 CONCORDANCE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG PRESCRIPTIONS WITH RECENT CLINICAL PRACTICE GUIDELINES IN QUEBEC, CANADA

    May 1, 2010, 00:00

  • PCV20 VENOUS THROMBOEMBOLIC COMPLICATIONS IN BURN PATIENTS RECEIVING HEPARIN OR ENOXAPARIN AS PROPHYLAXIS

    May 1, 2010, 00:00

  • PIH15 COST EFFECTIVENESS ANALYSIS OF FDA APPROVED ORAL EMERGENCY CONTRACEPTIVES

    May 1, 2010, 00:00

  • PCV94 CONCORDANCE AMONG THREE SELF-REPORTED MEASURES OF MEDICATION ADHERENCE AND COUNT OF TABLETS RECORDS IN COLOMBIAN HYPERTENSIVE PATIENTS

    May 1, 2010, 00:00

  • PCN152 TREATMENT PATTERNS IN ADULT PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES

    May 1, 2010, 00:00

  • PUK13 THE COST-EFFECTIVENESS OF EARLY SURGERY, ADDING BIOPSY, AND WATCHFUL WAITING IN THE MANAGEMENT OF SMALL SOLID RENAL MASSES- EVIDENCE FROM A MARKOV MODEL

    May 1, 2010, 00:00

  • PSY49 IMPACT OF DISEASE ON CAREER CHOICES, ABSENTEEISM, AND WORK LOSS AMONG INDIVIDUALS WITH PSORIASIS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCASE3 IMPACT OF DRUG POLICY ON IMPROVING ACCESS TO MEDICINES IN DELHI

    May 1, 2010, 00:00

  • PCN61 THE COST-EFFECTIVENESS OF CETUXIMAB USE AMONG ELDERLY METASTATIC COLORECTAL CANCER PATIENTS

    May 1, 2010, 00:00

  • PMH40 PATTERNS OF HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH GENERALIZED ANXIETY DISORDER INITIATING ADD-ON THERAPY WITH BENZODIAZEPINES

    May 1, 2010, 00:00

  • PCV58 ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM IN US HOSPITALS

    May 1, 2010, 00:00

  • PIN45 POLYMORBIDITY, THERAPY AND COSTS OF AMBULATORY CARE FOR HEPATITIS C PATIENTS IN GERMANY

    May 1, 2010, 00:00

  • PDB8 FEWER TREATMENT CHANGES WITH PREMIXED INSULIN ANALOGUES COMPARED TO PREMIXED HUMAN INSULIN-A REAL-LIFE TREATMENT PATTERN ANALYSIS OF PATIENTS WITH TYPE 2 DIABETES IN THE NETHERLANDS

    May 1, 2010, 00:00

  • PCV143 BELIEFS ABOUT ANTIHYPERTENSIVE MEDICATIONS IN PRIMARY CARE PATIENTS- VALIDATION OF BELIEFS ABOUT MEDICINES QUESTIONNAIRE (BMQ) IN COLOMBIA

    May 1, 2010, 00:00

  • PCV156 MODELING TRANSFORMED HEALTH CARE COSTS WITH UNKNOWN HETEROSKEDASTICITY

    May 1, 2010, 00:00

  • PHP34 RACIAL AND ETHNIC DISPARITIES IN THE PHARMACEUTICAL COST UNDER MEDICARE PART D

    May 1, 2010, 00:00

  • PMS11 THE DIRECT MEDICAL COSTS OF RHEUMATOID ARTHRITIS- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PRS6 EFFECT OF NICOTINE GUM PRICE ON MEDICATION ACQUISITION AND SMOKING CESSATION IN AN OVER-THE-COUNTER SETTING

    May 1, 2010, 00:00

  • PND31 IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS RECEIVING NATALIZUMAB IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCV54 THE INCIDENCE AND COST OF SURGICAL SITE INFECTION (SSI) FOR COMMON CARDIOTHORACIC SURGICAL PROCEDURES IN THE USA- A STUDY USING THE PREMIER PERSPECTIVE DATABASE (PPD)

    May 1, 2010, 00:00

  • PDB22 HEALTH CARE COSTS AND RESOURCE UTILIZATION OF PATIENTS WITH TYPE 2 DIABETES MELLITUS WITHIN A NATIONAL US MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PMC4 THE DERIVATION OF TRICARE SPECIFIC CONSUMER PRICE INDICES FOR PRESCRIPTION DRUGS

    May 1, 2010, 00:00

  • PCV138 ASSESSING THE IMPACT OF AN EMPLOYER SPONSORED COMMUNITY PHARMACY BASED MTM PROGRAM ON CLINICAL OUTCOMES FOR PATIENTS WITH DIABETES AND HYPERTENSION

    May 1, 2010, 00:00

  • PIN28 COST-EFFECTIVENESS ANALYSIS OF CHANGING FROM LIVE ORAL POLIOVIRUS VACCINE TO INACTIVATED POLIOVIRUS VACCINE IN COLOMBIA

    May 1, 2010, 00:00

  • PHP109 THE ECONOMIC IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN AMBULATORY SETTING IN GERMANY

    May 1, 2010, 00:00

  • PCN153 TREATMENT PATTERNS OF MEXICAN ONCOLOGISTS IN FIVE DIFFERENT MALIGNANCIES- A SURVEY

    May 1, 2010, 00:00

  • PRS22 COST-BENEFIT ANALYSIS OF VARENICLINE VS. EXISTING SMOKING CESSATION STRATEGIES IN PREGNANT WOMEN

    May 1, 2010, 00:00

  • PCN105 PATIENT PREFERENCE-BASED UTILITY WEIGHTS FROM THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL (FACT-G) IN WOMEN WITH HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER RECEIVING LETROZOLE PLUS LAPATINIB OR LETROZOLE ALONE

    May 1, 2010, 00:00

  • PCN46 FIRST YEAR INSURER AND PATIENT COSTS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DIAGNOSIS IN THE U.S. MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PIN39 A RETROSPECTIVE EVALUATION OF PATIENT ADHERENCE TO ANTIRETROVIRAL THERAPY- PROPORTION OF DAYS COVERED VERSUS MEDICATION POSSESSION RATIO

    May 1, 2010, 00:00

  • UT4 EVALUATING WILLINGNESS TO PAY THRESHOLDS FOR A DEMENTIA CAREGIVING INTERVENTION

    May 1, 2010, 00:00

  • PHP54 STUDY THE IMPACT OF AUTOREFILL PROGRAM ON MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PCV63 ECONOMIC IMPACT OF SWITCHING FROM VALSARTAN TO OTHER ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) IN PATIENTS WITH HYPERTENSION

    May 1, 2010, 00:00

  • PCV78 A PHARMACOECONOMICS ASSESSMENT OF SILDENAFIL IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION IN PEDIATRICS- THE MEXICAN CASE

    May 1, 2010, 00:00

  • PCN49 COSTS TO MEDICARE OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH ALEMTUZUMAB

    May 1, 2010, 00:00

  • PCV151 ASSESSMENT OF MEDICATION UTILIZATION PATTERN OF PATIENTS WITH SYSTOLIC HYPERTENSION AND COMPELLING INDICATIONS IN A PRIMARY CARE PRACTICE

    May 1, 2010, 00:00

  • PCN147 CHARACTERISTICS OF POSTMENOPAUSAL WOMEN INITIATING RALOXIFENE BEFORE AND AFTER APPROVAL OF INVASIVE BREAST CANCER RISK REDUCTION INDICATIONS

    May 1, 2010, 00:00

  • PSY11 THE INDIRECT COSTS OF INFLAMMATORY BOWEL DISEASE- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • TR1 THE EFFECT OF GENERIC DRUG ENTRY ON U.S. MEDICAID EXPENDITURES- 1991-2008

    May 1, 2010, 00:00

  • PMC35 ISSUES IN THE TRANSLATION AND LINGUISTIC VALIDATION OF EPRO AND IVRS INSTRUMENTS

    May 1, 2010, 00:00

  • PDB33 ECONOMIC EVALUATION OF THREE FIRST-LINE MEDICATIONS IN PAINFUL DIABETIC PERIPHERAL NEUROPHATY IN MEXICO

    May 1, 2010, 00:00

  • PDB50 THE IMPACT OF OBESITY AND QUALTY OF LIFE ON MEDICAL AND LOST PRODUCTIVITY COSTS IN DIABETIC PATIENTS

    May 1, 2010, 00:00

  • PHP57 MEDICATION USAGE BEHAVIOUR ASSESSMENT AMONGST OUTPATIENTS VISITING PUBLIC TEACHING HOSPITAL

    May 1, 2010, 00:00

  • PND40 THE IMPORTANCE OF GUIDELINES FOR CLINROS- THE ADAS-COG, A CASE STUDY

    May 1, 2010, 00:00

  • PND5 COMPARISON OF DIRECT AND INDIRECT COSTS IN EMPLOYEES WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY TREATED WITH PREGABALIN OR DULOXETINE

    May 1, 2010, 00:00

  • PND30 NATALIZUMAB TREATMENT IS ASSOCIATED WITH AN IMPROVEMENT IN PATIENT-REPORTED FATIGUE AND COGNITIVE FUNCTION OVER TIME

    May 1, 2010, 00:00

  • PDB21 MEDICAL COST AND SETTLEMENT PATTERN STUDY ON DIABETES MELLITUS INSURANTS IN CHINA

    May 1, 2010, 00:00

  • PCV46 A FRENCH HOSPITAL BUDGET IMPACT MODEL COMPARING ANTICOAGULATION STRATEGIES IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION

    May 1, 2010, 00:00

  • PHP81 UNITED STATES PHD PROGRAMS IN PHARMACOECONOMICS AND OUTCOMES RESEARCH

    May 1, 2010, 00:00

  • PMH79 STATISTICAL ANALYSIS OF DIAGNOSIS RELATED GROUP 521- ALCOHOL/DRUG ABUSE OR DEPENDENCE WITH COMPLICATIONS AND COMORBIDITIES

    May 1, 2010, 00:00

  • PMS15 COMPARISON OF MEDICAL RESOURCE USE AND COSTS ASSOCIATED WITH FIBROMYALGIA IN FRANCE, GERMANY AND THE UNITED STATES

    May 1, 2010, 00:00

  • PSS6 THE COST-EFFECTIVENESS OF ISOTRETINOIN IN PATIENTS WITH MODERATE-TO-SEVERE ACNE VULGARIS

    May 1, 2010, 00:00

  • PMC36 VALIDITY OF SELF-REPORT WITH RESPECT TO PRESCRIPTION MEDICATIONS AMONG PREGNANT WOMEN

    May 1, 2010, 00:00

  • PRS47 COMPARING RISK ADJUSTMENT MODELS- PROPENSITY SCORE MATCHING, STANDARD REGRESSION ANALYSIS AND INSTRUMENTAL VARIABLE METHOD

    May 1, 2010, 00:00

  • PUK24 THE IMPACT OF ADDING A RACIAL CASE MIX ADJUSTER TO MEDICARE DIALYSIS REMIBURSEMENT- CORRECTING A POTENTIAL BIAS

    May 1, 2010, 00:00

  • PSY8/CM3 PERSISTENCE WITH INFLIXIMAB MAINTENANCE THERAPY DECREASES HOSPITALIZATIONS IN PATIENTS WITH ULCERATIVE COLITIS

    May 1, 2010, 00:00

  • PHP12 THE RELATIONSHIP OF RESEARCH AND DEVELOPMENT ACTIVITY WITH U.S. MEDICAL DRUG SHORTAGES

    May 1, 2010, 00:00

  • PND1 CLINICAL AND PHARMACY UTILIZATION OUTCOMES WITH BRAND TO GENERIC ANTIEPILEPTIC UTILIZATION IN PATIENTS WITH EPILEPSY

    May 1, 2010, 00:00

  • PMC21 PATIENT-REPORTED OUTCOMES IN PRODUCT DEVELOPMENT GUIDANCE

    May 1, 2010, 00:00

  • PCV128 RELATIONSHIPS BETWEEN PHYSICAL INACTIVITY AND HEALTH CARE EXPENDITURE AND RESOURCE USE IN PATIENTS WITH PRIMARY HYPERTENSION

    May 1, 2010, 00:00

  • PIN1 HEPATITIC-C BURDEN ASSESSMENT IN FRANCE FROM A TRANSMISSION MODEL

    May 1, 2010, 00:00

  • PCV134 READMISSIONS AFTER UNAUTHORIZED DISCHARGES IN THE CARDIOVASCULAR SETTING

    May 1, 2010, 00:00

  • PMH52 ECONOMIC ANALYSIS OF ESCITALOPRAM (GENERIC DRUG) IN MAJOR DEPRESSIVE DISORDER (MDD)

    May 1, 2010, 00:00

  • PIN18 COST-EFFECTIVENESS OF UNIVERSAL INFLUENZA VACCINATION IN THE US

    May 1, 2010, 00:00

  • PCV16 AN ASSESSMENT OF OPTIMAL LIPID VALUE ATTAINMENT AND ASSOCIATED DYSLIPIDEMIA TREATMENT PATTERNS FROM 2005 TO 2009 IN A COMMERCIALLY INSURED POPULATION

    May 1, 2010, 00:00

  • PCV139 EVALUATION OF A HEALTH CARE PROVIDER INTERVENTION TO INITIATE ACEI OR ARB THERAPY AMONG PATIENTS WITH DIABETES PLUS HYPERTENSION AND/OR NEPHROPATHY

    May 1, 2010, 00:00

  • PCN132 COST OF BREAST AND CERVICAL CANCER TREATMENT AND FOLLOW-UP CARE IN MEDICAID BENEFICARIES- IMPLICATIONS FOR STATE PROGRAMS PROVIDING COVERAGE FOR LOW-INCOME WOMEN

    May 1, 2010, 00:00

  • PHP44 ANNUAL HEALTH INSURANCE COST OF SPA SERVICES IN HUNGARY

    May 1, 2010, 00:00

  • PDB75 EFFECTS OF STATIN THERAPY ON HOSPITALIZATION AND MORTALITY IN PATIENTS WITH DIABETES- A RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PCV159 COMPARATIVE EFFECTIVENESS INDEX- A CONCEPTUAL APPROACH TO COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2010, 00:00

  • PMC44 AN EVALUATION OF THE STATISTICAL EFFICIENCY OF THE US POPULATION MEDIAN-BASED EQ-5D INDEX USING DATA FROM THE MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2010, 00:00

  • PHP41 USE OF ECONOMIC EVIDENCE IN PHARMACEUTICAL MARKETING AUTHORIZATION PROCEDURES, FIRST EXPERIENCE FROM IRAN

    May 1, 2010, 00:00

  • PMS43 HEALTH-RELATED QUALITY OF LIFE IN PERIOPERATIVE PAIN MANAGEMENT PATIENTS AFTER ORTHOPEDIC SURGERY(TOTAL KNEE ARTHROPLASTY AND SPINAL FUSION)

    May 1, 2010, 00:00

  • PMH48 VALIDATING A COST-EFFECTIVENESS ANALYSIS COMPARING OLANZAPINE WITH ZIPRASIDONE IN THE TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PMH58 ASSESSMENT OF HEALTH CARE UTILIZATION AND COST AMONG PATIENTS WITH BIPOLAR I DISORDER TREATED WITH ANTIPSYCHOTIC THERAPY IN A MULTISTATE MEDICAID POPULATION

    May 1, 2010, 00:00

  • PRS23 THE POTENTIAL COST IMPACT OF USING A PEG HYDROGEL SEALANT TO PREVENT AIR LEAKS AFTER LUNG RESECTION SURGERY IN THE UNITED KINGDOM

    May 1, 2010, 00:00

  • PCV73 CONSIDERING THE COST-EFFECTIVENESS OF STATINS IN FAMILY PRACTICE IN TURKEY FROM A PAYER PERSPECTIVE

    May 1, 2010, 00:00

  • CV2 USING AN INTERRUPTED TIME SERIES ANALYSIS TO ASSESS THE IMPACT OF VALSARTAN INITIATION ON MEDICAL COSTS FOR PATIENTS WITH HYPERTENSION

    May 1, 2010, 00:00

  • PHP83 QUALITY ASSURANCE OF FOURTH HURDLE WITHIN THE SLOVAK REPUBLIC

    May 1, 2010, 00:00

  • PGI24 COST UTILITY ANALYSIS OF CERTOLIZUMAB PEGOL VERSUS NATALIZUMB MAINTENANCE THERAPY FOR CROHNS DISEASE

    May 1, 2010, 00:00

  • PCV45 BUDGET IMPACT OF BIVALIRUDIN IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) IN GERMAN HOSPITALS

    May 1, 2010, 00:00

  • PCN30 EFFECTS OF ADDING CHEMOTHERAPY-SPECIFIC DISCONTINUATION AND DOSE DELAY/REDUCTIONS TO FEBRILE NEUTROPENIA PROPHYLAXIS DECISION MODELS

    May 1, 2010, 00:00

  • PSS11 COST-UTILITY ANALYSIS OF MAINTENANCE TREATMENT WITH TACROLIMUS OINTMENT IN ADULTS AND CHILDREN WITH MODERATE AND SEVERE ATOPIC DERMATITIS

    May 1, 2010, 00:00

  • PMH63 EVALUATING PATIENT ADHERENCE TO ANTIDEPRESSANT THERAPY AMONG UNINSURED WORKING ADULTS DIAGNOSED WITH MAJOR DEPRESSION- 12-MONTH RESULTS FROM THE TEXAS DEMONSTRATION TO MAINTAIN INDEPENDENCE AND EMPLOYMENT (DMIE) STUDY

    May 1, 2010, 00:00

  • PHP36 ECONOMIC MODELS- MANAGED CARE DECISION MAKERS PERCEPTIONS AND USE

    May 1, 2010, 00:00

  • PMH50 COSTS AND EFFECTS OF ILOPERIDONE COMPARED WITH OLANZAPINE AND HALOPERIDOL IN PATIENTS WITH ACUTE SCHIZOPHRENIA- RESULTS FROM A COST-EFFECTIVENESS MARKOV MODEL

    May 1, 2010, 00:00

  • PMS20 COST EFFECTIVENESS ANALYSIS OF MANAGING CHRONIC GOUT WITH FEBUOXSTAT (ULORIC) VERSUS ALLOPURINOL (ZYLOPRIM)

    May 1, 2010, 00:00

  • PCV127 CARDIOVASCULAR DRUGS USAGE IN CROATIA AND SLOVENIA DURING THE NINE-YEAR PERIOD

    May 1, 2010, 00:00

  • RM2 IMPACT OF ADHERENCE WITH STATIN THERAPY ON HOSPITALIZATION RISK AND MORTALITY AMONG PATIENTS WITH DIABETES

    May 1, 2010, 00:00

  • PMC30 AGREEMENT BETWEEN PROMIS GLOBAL HEALTH SCALE AND SF-36 SCORES AMONG SURGICAL PATIENTS

    May 1, 2010, 00:00

  • PUK25 CASE MIX ADJUSTMENT- THE CONSEQUENCES OF DIVERGENCE IN ACCESS TO DATA

    May 1, 2010, 00:00

  • PCV10 A META-ANALYSIS OF CARDIOVASCULAR RISK FACTORS- WHICH IS THE DIFFERENCE BETWEEN MEN AND WOMEN?

    May 1, 2010, 00:00

  • PHP110 ASSESSING THE OUTCOME OF ELBOW SURGERY- DEVELOPMENT, VALIDATION AND RESPONSIVENESS OF THE PATIENT-REPORTED OXFORD ELBOW SCORE (OES)

    May 1, 2010, 00:00

  • PHP7 COMPARING POTENTIAL STRATEGIES TO ELIMINATING MEDICARE PART DS COVERAGE GAP

    May 1, 2010, 00:00

  • PCV102 HEALTH BELIEFS AND THEIR IMPACT ON MEDICATION ADHERENCE IN PATIENTS WITH COEXISTING DIABETES, DYSLIPIDEMIA AND HYPERTENSION

    May 1, 2010, 00:00

  • PIN10 CLINICAL AND ECONOMIC OUTCOMES OF INVASIVE ASPERGILLOSIS (IA) IN THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) NON-TRADITIONAL HOST- A HOSPITAL DATABASE ANALYSIS

    May 1, 2010, 00:00

  • PMH89 TRENDS IN U.S. OUTPATIENT PHYSICIAN VISITS AND MEDICATION TREATMENT PATTERNS FOR PEDIATRIC ADHD- 1998-2007

    May 1, 2010, 00:00

  • PMC3 REVIEW OF COST EFFECTIVENESS ANALYSES THAT INCORPORATE NUMBER NEEDED TO TREAT/HARM VALUES

    May 1, 2010, 00:00

  • PND37 PROJECTING THE BURDEN OF ALZHEIMERS DISEASE IN THE UNITED STATES

    May 1, 2010, 00:00

  • PGI26 CANADIAN COST-UTILITY ANALYSIS OF INITIATION AND MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS FOR REFRACTORY CROHNS DISEASE

    May 1, 2010, 00:00

  • PDB62 EFFECTS OF HEALTH INSURANCE PLAN TYPE ON HEALTH CARE RESOURCE UTILIZATION IN ADULT WORKING AGE PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2010, 00:00

  • PCN42 INDIRECT COST ASSOCIATED WITH BREAST CANCER TO US EMPLOYERS

    May 1, 2010, 00:00

  • PCV157 ACCOUNTING FOR TRIAL-EXCLUDED MEDICAL CONDITIONS WHEN SIMULATING MORTALTIY IN CLINICAL TRIAL POPULATIONS

    May 1, 2010, 00:00

  • PDB38 THE IMPACT OF DIABETES ON WORKPLACE PRESENTEEISM- A CROSS NATIONAL STUDY IN THE EUROPEAN UNION

    May 1, 2010, 00:00

  • PCN51 HEALTH CARE COSTS ASSOCIATED WITH ANGIOGENESIS INHIBITORS (AIS) AND MTOR INHIBITORS (MTORS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED AT US COMMUNITY ONCOLOGY CLINICS

    May 1, 2010, 00:00

  • PMH21 PREVALENCE AND PREDICTORS OF ANTICHOLINERGIC MEDICATION USE IN ELDERLY NURSING HOME RESIDENTS WITH DEMENTIA

    May 1, 2010, 00:00
  • «
  • 141
  • 142
  • 143
  • 144
  • 145 (current)
  • 146
  • 147
  • 148
  • 149
  • 150
  • »